Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study

Soley Bayraktar; Sema Baghaki; Jimin Wu; Diane D. Liu; Angelica M. Gutierrez-Barrera; Therese B. Bevers; Vicente Valero; Nour Sneige; Banu K. Arun

doi:10.1158/1940-6207.CAPR-20-0095

Research Article

Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study

Soley Bayraktar, Sema Baghaki, Jimin Wu, Diane D. Liu, Angelica M. Gutierrez-Barrera, Therese B. Bevers, Vicente Valero, Nour Sneige and Banu K. Arun

Soley Bayraktar

1Division of Medical Oncology and Hematology, Department of Medicine, Biruni University School of Medicine, Istanbul, Turkey.

2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sema Baghaki

2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Sema Baghaki

Jimin Wu

3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Diane D. Liu

3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Angelica M. Gutierrez-Barrera

2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Therese B. Bevers

4Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vicente Valero

2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nour Sneige

5Department of Cytopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Banu K. Arun

2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: barun@mdanderson.org

DOI: 10.1158/1940-6207.CAPR-20-0095 Published September 2020

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

PreviousNext

September 2020
Volume 13, Issue 9

Table of Contents
Table of Contents (PDF)
About the Cover
Editorial Board (PDF)

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Prevention Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study

Message Subject (Your Name) has forwarded a page to you from Cancer Prevention Research

Message Body (Your Name) thought you would be interested in this article in Cancer Prevention Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study

Soley Bayraktar, Sema Baghaki, Jimin Wu, Diane D. Liu, Angelica M. Gutierrez-Barrera, Therese B. Bevers, Vicente Valero, Nour Sneige and Banu K. Arun

Cancer Prev Res September 1 2020 (13) (9) 795-802; DOI: 10.1158/1940-6207.CAPR-20-0095

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study

Soley Bayraktar, Sema Baghaki, Jimin Wu, Diane D. Liu, Angelica M. Gutierrez-Barrera, Therese B. Bevers, Vicente Valero, Nour Sneige and Banu K. Arun

Cancer Prev Res September 1 2020 (13) (9) 795-802; DOI: 10.1158/1940-6207.CAPR-20-0095

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Main menu

User menu

Search

Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study

Purchase access

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Articles

Info for

About Cancer Prevention Research